Vice President Andrea Hugill to Speak at ACI’s 17th Summit on Biosimilars & Innovator Biologics
Event:17th Summit on Biosimilars & Innovator Biologics
Date:
June 2, 2026
Host:
American Conference Institute (ACI)
Location:
New York, NY
Times:
12:00–1:00 p.m. (PT) / 3:00–4:00 p.m. (ET)
Vice President Andrea Hugill will join the panel Manufacturing Patents as the New Battleground: Protecting Biologics Manufacturing at the American Conference Institute’s 17th Summit on Biosimilars & Innovator Biologics. The panel will explore how companies are leveraging manufacturing patents and trade secrets to protect biologics manufacturing processes and preserve market exclusivity, and how courts are assessing infringement arguments based on process overlap, analytical characterization, and product-by-process claim frameworks.
Dr. Hugill will be joined by Maureen Bresnahan (Eisai), Jeffrey Jacobstein (Finnegan, Henderson, Farabow, Garrett & Dunner), Mary Morry (Merck Sharp & Dohme), and Matthew Murphy (Axinn, Veltrop & Harkrider).
Analysis Group is pleased to be an associate sponsor of this event.